Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1505-1511

  Surtees, Robert ^a   Clelland, James ^a   Hann, Ian ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; DRUG METABOLITE; FOLINIC ACID; METHIONINE; METHOTREXATE; MYELIN BASIC PROTEIN; S ADENOSYLMETHIONINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RADIOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATION; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031947878     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1505     Document Type: Article

References (39)

1. Stehbens JA, Kaleita TA, Noll RB, et al: CNS prophylaxis of childhood leukemia: What are the long-term neurological, neuropsychological, and behavioral effects? Neuropsychol Rev 2:147-177, 1991
2. Wilson DA, Nitschke R, Bowman ME, et al: Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: Correlation with neuropsychologic deficiencies. Radiology 180:205-209, 1991
3. Paakko E, Vainionpaa L, Lanning M, et al: White matter changes in children treated for acute lymphoblastic leukemia. Cancer 70:2728-2733, 1992
4. Asato R, Akiyama Y, Ito M, et al: Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 70:1997-2004, 1992
5. Paakko E, Vainionpaa L, Pyhtinen J, et al: Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia. Neuroradiology 38:264-268, 1996
6. Kamen BA: Methotrexate, folate and the brain. Neurotoxicology 7:209-216, 1986
7. Quinn CT, Kamen BA: A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Invest Med 44:522-530, 1996
8. Matthews RG, Haywood BJ: Inhibition of pig liver methylenetetrahydrofolate reductase by dihydrofolate: Some mechanistic and regulatory implications. Biochemistry 18:4845-4851, 1979
9. Surtees R, Leonard J, Austin S: Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338:1550-1554, 1991
10. Lee CC, Surtees R, Duchen LW: Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain 115:935-955, 1992
11. Gangji D, Reaman GH, Cohen SR, et al: Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med 303:19-21, 1980
12. Mahoney DH Jr, Fernbach DJ, Glaze DG, et al: Elevated myelin basic protein levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia. J Clin Oncol 2:58-61, 1984
13. Davies L, McLeod JG, Muir A, et al: Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness. Clin Exp Neurol 24:5-10, 1987
14. Surtees R, Hyland K: Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolate in a reference population: cerebrospinal fluid S-adenosylmethionine declines with age in humans. Biochem Med Metab Biol 44:192-199, 1990
15. Surtees R, Hyland K: A method for the measurement of S-adenosylmethionine in small volume samples of cerebrospinal fluid or brain using high-performance liquid chromatography-electrochemistry. Anal Biochem 181:331-335, 1989
16. Hyland K, Surtees R: Measurement of 5-methyltetrahydrofolate in cerebrospinal fluid using HPLC with coulometric electrochemical detection. Pteridines 3:149-150, 1992
17. Chanarin I: The Megaloblastic Anaemias (ed 2). Oxford, United Kingdom, Blackwell Scientific, 1979, pp 187-229
18. Broxson EH Jr, Stork LC, Allen RH, et al: Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res 49:5879-5883, 1989
19. Refsum H, Wesenberg F, Ueland PM: Plasma homocysteine in children with acute lymphoblastic leukemia: Changes during a chemotherapeutic regimen including methotrexate. Cancer Res 51:828-835, 1991
20. Keuzenkamp Jansen CW, De Abreu RA, Blom HJ, et al: Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia. Biochem Pharmacol 51:1165-1171, 1996
21. Quinn CT, Griener JC, Bottiglieri T, et al: Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 15:2800-2806, 1997
22. McLaurin J, Ackerley CA, Moscarello MA: Localisation of basic proteins in human myelin. J Neurosci Res 35:618-628, 1993
23. Ghosh SK, Syed SK, Jung S, et al: Substrate specificity for myelin basic protein-specific protein methylase I. Biochim Biophys Acta 1039:142-148, 1990
24. Young PR, Vacante DA, Waickus CM: Mechanism of the interaction between myelin basic protein and the myelin membrane: The role of arginine methylation. Biochem Biophys Res Commun 145:1112-1118, 1987
25. Ghosh SK, Rawal N, Syed SK, et al: Enzymatic methylation of myelin basic protein in myelin. Biochem J 275:381-387, 1997
26. Bernini JC, Fort DW, Griener JC, et al: Aminophylline for methotrexate-induced neurotoxicity. Lancet 345:544-547, 1995
27. de la Haba G, Cantoni G: The enzymatic synthesis of S-adenosyl-L-methionine from adenosine and homocysteine. J Biol Chem 234:603-608, 1959
28. Hoffman DR, Marion DW, Cornatzer WE, et al: S-adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocysteine, and adenosine. J Biol Chem 255:10822-10827, 1980
29. Schatz RA, Wilens TE, Sellinger OZ: Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-1-homocysteine. J Neurochem 36:1739-1748, 1981
30. Schatz RA, Wilens TE, Sellinger OZ: Decreased in vivo protein and phospholipid methylation after in vivo elevation of brain S-adenosylhomocysteine. Biochem Biophys Res Commun 98:1097-1107, 1981
31. 2 intravenous methotrexate. Pediatr Res 37:151-154, 1995
32. Williams KS, Ochs J, Williams JM, et al: Parental report of everyday cognitive abilities among children treated for acute lymphoblastic leukemia. J Pediatr Psychol 16:13-26, 1991
33. Ochs J, Mulhern R, Fairclough D, et al: Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol 9:145-151, 1991
34. Brown RT, Madan Swain A, Pais R, et al: Chemotherapy for acute lymphocytic leukemia: Cognitive and academic sequelae. J Pediatr 121:885-889, 1992
35. Giralt J, Ortega JJ, Olive T, et al: Long-term neuropsychologic sequelae of childhood leukemia: Comparison of two CNS prophylactic regimens. Int J Radiat Oncol Biol Phys 24:49-53, 1992
36. Waber DP, Tarbell NJ, Kahn CM, et al: The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 10:810-817, 1992
37. Bakke SJ, Fossen A, Storm Mathiesen I, et al: Long-term cerebral effects of CNS chemotherapy in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 10:267-270, 1993
38. Copeland DR, Moore BD III, Francis DJ, et al: Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. J Clin Oncol 14:2826-2835, 1996
39. Butler RW, Hill JM, Steinherz PG, et al: Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 12:2621-2629, 1994